Splenic Gene Delivery System Using Self-assembling Nano-complex with Phosphatidylserine Analog
-
- Kurosaki Tomoaki
- Department of Hospital Pharmacy, Nagasaki University Hospital
-
- Nakasone Chihiro
- Department of Hospital Pharmacy, Nagasaki University Hospital
-
- Kodama Yukinobu
- Department of Hospital Pharmacy, Nagasaki University Hospital
-
- Egashira Kanoko
- Department of Hospital Pharmacy, Nagasaki University Hospital
-
- Harasawa Hitomi
- Department of Hospital Pharmacy, Nagasaki University Hospital
-
- Muro Takahiro
- Department of Hospital Pharmacy, Nagasaki University Hospital
-
- Nakagawa Hiroo
- Department of Hospital Pharmacy, Nagasaki University Hospital
-
- Kitahara Takashi
- Department of Hospital Pharmacy, Nagasaki University Hospital
-
- Higuchi Norihide
- Department of Hospital Pharmacy, Nagasaki University Hospital
-
- Nakamura Tadahiro
- Department of Hospital Pharmacy, Nagasaki University Hospital
-
- Sasaki Hitoshi
- Department of Hospital Pharmacy, Nagasaki University Hospital
この論文をさがす
抄録
The recognition of phosphatidylserine on the erythrocyte membrane mediates erythrophagocytosis by resident spleen macrophages. The application of phosphatidylserine to a gene vector may be a novel approach for splenic drug delivery. Therefore, we chose 1,2-dioleoyl-sn-glycero-3-phospho-L-serin (DOPS) as an analogue of phosphatidylserine for splenic gene delivery of plasmid DNA (pDNA). In the present study, we successfully prepared a stable pDNA ternary complex using DOPS and polyethyleneimine (PEI) and evaluated its efficacy and safety. The pDNA/PEI complex had a positive charge and showed high transgene efficacy, although it caused cytotoxicity and agglutination. The addition of DOPS changed the ζ-potential of the pDNA/PEI complex to negative. It is known that anionic complexes are not taken up well by cells. Surprisingly, however, the pDNA/PEI/DOPS complex showed relatively high transgene efficacy in vitro. Fluorescence microscope observation revealed that the pDNA/PEI/DOPS complex internalized the cells while maintaining the complex formation. The injection of the pDNA/PEI complex killed most mice within 24 h at high doses, although all mice in the pDNA/PEI/DOPS complex group survived. The ternary complex with DOPS showed markedly better safety compared with the pDNA/PEI complex. The pDNA/PEI/DOPS complex showed high gene expression selectively in the spleen after intravenous injection into mice. Thus the ternary complex with DOPS can be used to deliver pDNA to the spleen, in which immune cells are abundant. It appears to have an excellent safety level, although further study to determine the mechanism of action is necessary.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 38 (1), 23-29, 2015
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282679607943040
-
- NII論文ID
- 130004872233
-
- NII書誌ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- HANDLE
- 10069/35065
-
- NDL書誌ID
- 026000769
-
- PubMed
- 25744454
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- IRDB
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可